Market revenue in 2023 | USD 55.7 million |
Market revenue in 2030 | USD 70.5 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 20.65% in 2023. Horizon Databook has segmented the Brazil point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil, being the fifth largest country in the world and most developed in Latin America, is a potential market for POC diagnostic products. Healthcare reforms such as Unified Health System (SUS) in Brazil are estimated to boost the usage rates of POC devices.
Moreover, various initiatives being undertaken by companies in the country to develop efficient POC diagnostic tests are expected to drive the market growth in the coming years. According to International Diabetes Federation, there were around 16.7 million people suffering from diabetes, with prevalence rate of 11.4%, in 2019.
Brazil has the most structured healthcare system. Availability of free solutions used to treat diabetes such as test strips, syringes, and glucose monitors in the country is expected to boost the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account